Precautions for taking Indian Haideronib: bleeding risk, atrial fibrillation, and infection monitoring
Ibrutinib, as a BTK inhibitor, should focus on the risks of bleeding, atrial fibrillation, and infection. Regular monitoring of relevant indicators is required during medication, and treatment plans should be adjusted according to clinical indications. The following provides a detailed explanation of precautions from three aspects: bleeding management, arrhythmia prevention and control, and infection monitoring.
1. Bleeding risk management
(1) Risk level and performance
Severe bleeding events include intracranial hemorrhage, gastrointestinal bleeding, and other bleeding of grade 3 or above. The risk is significantly increased when anticoagulants/antiplatelet drugs are used in combination.
(2) Monitoring and Intervention
During the treatment period, it is necessary to observe abnormal bleeding signs (such as black stool and hematuria) and regularly test platelets. When bleeding occurs, it is necessary to evaluate whether to suspend medication or adjust anticoagulant regimen.
(3) Daily protection
Avoid contact sports and use a soft bristled toothbrush. Before performing invasive procedures, it is necessary to evaluate the medication plan with a doctor.
2. Key points for monitoring atrial fibrillation
(1) Clinical manifestations
Common palpitations, difficulty breathing, or fainting can lead to heart failure or sudden death in severe cases. Individuals with a history of cardiovascular disease have a higher risk.
(2) Electrocardiogram monitoring
Regularly check the electrocardiogram during baseline and treatment. Immediate assessment is necessary when symptoms appear, and medication may be suspended or antiarrhythmic drugs may be used if necessary.
(3) Blood pressure control
Patients with combined hypertension need to strengthen blood pressure monitoring, and it is recommended to measure at home 2-3 times a week to maintain blood pressure<140/90mmHg.
3. Infection prevention and control measures
(1) High risk infection types
Including opportunistic infections such as bacterial pneumonia, fungal infections, and progressive multifocal leukoencephalopathy.
(2) Preventive strategies
High risk patients can use antibiotics preventively. Complete vaccination before treatment and avoid contact with the source of infection.
(3) Symptom monitoring
If you experience persistent fever, cough, or neurological symptoms, seek medical attention immediately. Perform monthly blood routine tests and intervene when the neutrophil count is less than 1.0 × 10 ⁹/L.
Disclaimer：《Precautions for taking Indian Haideronib: bleeding risk, atrial fibrillation, and infection monitoring》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！